Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Lorenzo Azzalini

Interventional Cardiology Seattle, WA Medical Doctor

NPI 1821562505 CMS profile 5820949

1959 Ne Pacific St, Seattle, WA 98195

Open in the dashboard

General payments

$232,615

354 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$77,440 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Lorenzo Azzalini of Seattle, WA is reported in the CMS Open Payments database as having received $232,615 across 354 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $77,440 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $52,623 58
2024 General $17,701 37
2023 General $52,538 48
2022 General $58,068 50
2021 General $43,336 52
2020 General $6,836 58
2019 General $1,514 51

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lorenzo Azzalini
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Lorenzo Azzalini were reported at $52,623. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Lorenzo Azzalini Interventional Cardiology median Middle half National median
2019 $1,514 $1,097 $329–$3,048 $163
2020 $6,836 $473 $161–$1,480 $114
2021 $43,336 $677 $233–$1,827 $132
2022 $58,068 $978 $333–$2,724 $149
2023 $52,538 $1,136 $382–$2,986 $160
2024 $17,701 $1,181 $395–$3,326 $164
2025 $52,623 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abiomed $66,050 56 payments
  2. Teleflex LLC $41,269 40 payments
  3. Ge Healthcare $31,546 16 payments
  4. Cardiovascular Systems Inc. $27,751 55 payments
  5. Shockwave Medical, Inc $24,628 32 payments
  6. Abbott Laboratories $15,538 25 payments
  7. Reflow Medical Inc $7,512 6 payments
  8. Boston Scientific Corporation $6,351 32 payments
  9. Arrow International, Inc. $4,329 4 payments
  10. Asahi Intecc USA, Inc. $2,272 4 payments
  11. Other $5,368 84 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $62,223 30 payments
  2. Honoraria $57,975 19 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $49,744 16 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $29,230 8 payments
  5. Travel and Lodging $15,363 36 payments
  6. Food and Beverage $13,320 243 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $4,760 2 payments
Products named General payments · program years 2019–2025
  1. Impella $63,628 53 payments
  2. TURNPIKE $24,994 18 payments
  3. Diamondback Coronary Atherectomy Device $20,742 18 payments
  4. OEC $20,370 6 payments
  5. Diamondback Peripheral $16,135 8 payments
  6. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Lithoplasty $12,432 16 payments
  7. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Cardiology $11,791 13 payments
  8. Diamondback Coronary Vascular $8,765 7 payments
  9. GUIDELINER $8,618 9 payments
  10. GUIDELINER V3 CATHETER $7,265 5 payments
  11. Other $32,573 186 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 46 billing codes

Paid by Medicare

$87,871

Medicare's payments for the services billed

Medicare patients

108

Average age 73

Services billed

527

26 women, 82 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 63%
Diabetes 50%
Chronic kidney disease 49%
Atrial fibrillation 31%
Depression 28%
Arthritis 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

354 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record